Search
for

    Sort by

    Research 31–60 of 113

    1. Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis Neurodegenerative disease management · 2013
    2. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    3. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Rheumatology · 2017 · 213 citations
    4. Lupus erythematosus: systemic and cutaneous manifestations Clinics in Dermatology · 2006 · 144 citations
    5. Fibromyalgia, Systemic Lupus Erythematosus (SLE), and Evaluation of SLE Activity The Journal of Rheumatology · 2008 · 107 citations
    6. Acne-associated syndromes: models for better understanding of acne pathogenesis Journal of The European Academy of Dermatology and Venereology · 2010 · 99 citations
    7. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    8. Methotrexate in dermatology Dermatologic Therapy · 2007 · 77 citations
    9. Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions Multiple Sclerosis and Related Disorders · 2015 · 72 citations
    10. Drug-induced acne Clinics in Dermatology · 2016 · 52 citations
    11. Drug-Induced Hair Disorders Current Drug Safety · 2006 · 40 citations
    12. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    13. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus JAMA Dermatology · 2017 · 16 citations
    14. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis Expert Opinion on Pharmacotherapy · 2014 · 16 citations
    15. Severe diffuse non-scarring hair loss in systemic lupus erythematosus - clinical and histopathological analysis of four cases Journal of the European Academy of Dermatology and Venereology · 2011 · 15 citations
    16. Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore Pharmacology Research & Perspectives · 2019 · 13 citations
    17. A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus Revista Brasileira de Ginecologia e Obstetrícia · 2018 · 12 citations
    18. Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus Biologics: Targets & Therapy · 2011 · 9 citations
    19. Ottawa, Ontario, Canada, February 13–16, 2013 The Journal of Rheumatology · 2013 · 4 citations
    20. Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases Chemical Immunology · 2012 · 4 citations
    21. Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review Archives of Dermatological Research · 2025 · 3 citations
    22. Acne and acneiform eruptions Elsevier eBooks · 2011 · 2 citations
    23. LUPUS ERYTHEMATOSUS AND THE SKIN Elsevier eBooks · 2004 · 2 citations
    24. ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT The Journal of Rheumatology · 2025 · 1 citations
    25. JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison Frontiers in Molecular Biosciences · 2026
    26. Real-world pharmacovigilance insights into drug-induced risk of alopecia Frontiers in Pharmacology · 2025
    27. ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES The Journal of Rheumatology · 2025
    28. MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP The Journal of Rheumatology · 2025
    29. Nanoemulgels: A new approach for the treatment of skin-related disorders International Journal of Pharmaceutical Quality Assurance · 2024
    30. Clinical Profile and Outcomes of Patients With Systemic Lupus Erythematosus Cureus · 2024